Achilles Therapeutics plc (ACHL)

NASDAQ: ACHL · IEX Real-Time Price · USD

0.823

-0.027 (-3.22%)

At close: Apr 15, 2024, 4:00 PM

0.820

-0.002 (-0.30%)

After-hours: Apr 15, 2024, 7:30 PM EDT

Achilles Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-69.67	-71.18	-61.1	-33.2	-13.99
Depreciation & Amortization	4.71	3.69	3.29	0.77	0.3
Share-Based Compensation	6.36	7.02	6.32	2.99	0.72
Other Operating Activities	10.15	0.93	-7.79	4.18	-1.17
Operating Cash Flow	-48.45	-59.54	-59.28	-25.25	-14.14
Capital Expenditures	-1.1	-7.51	-7.63	-11.85	-0.94
Investing Cash Flow	-1.1	-7.51	-7.63	-11.85	-0.94
Share Issuance / Repurchase	0.01	0	160.76	-0.12	0
Other Financing Activities	-	-	-	113.83	93.62
Financing Cash Flow	0.01	0	160.76	113.7	93.62
Exchange Rate Effect	7.74	-25.94	-5.33	3.65	8.37
Net Cash Flow	-41.8	-92.98	88.5	80.26	86.91
Free Cash Flow	-49.55	-67.05	-66.92	-37.1	-15.08
Free Cash Flow Per Share	-1.24	-1.71	-2.33	-34.80	-23.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).